Pharmaceuticals Kenya

Kenya Insomnia Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Kenya Insomnia Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Kenya · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.2 Mn Placeholder estimate
Estimate 2025 $2.4 Mn 0.1% of the global market
Projected 2034 $3.9 Mn 66.1% Adds $1.6 Mn over 9 forecast years
CAGR 2025–2034 5.8% Faster than 13% of 180 Pharmaceuticals markets here
Key players 5
  • Kenya is 0.07% of the global market.
  • In Africa, the largest is South Africa at $20.2 Mn.
  • Fastest growing: South Africa at 6.5% a year.
  • Kenya ranks 3rd of 3 by size in Africa.

Market size projection

Kenya

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insomnia Treatment Market market size by year, Kenya
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.2 Mn — —
2025 (base) $2.4 Mn +$0.1 Mn —
2026 (forecast) $2.5 Mn +$0.1 Mn +5.8%
2027 (forecast) $2.6 Mn +$0.1 Mn +11.9%
2028 (forecast) $2.8 Mn +$0.2 Mn +18.4%
2029 (forecast) $2.9 Mn +$0.2 Mn +25.3%
2030 (forecast) $3.1 Mn +$0.2 Mn +32.6%
2031 (forecast) $3.3 Mn +$0.2 Mn +40.3%
2032 (forecast) $3.5 Mn +$0.2 Mn +48.4%
2033 (forecast) $3.7 Mn +$0.2 Mn +57%
2034 (forecast) $3.9 Mn +$0.2 Mn +66.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.31 Bn
  2. North America $1.38 Bn
  3. US $1.18 Bn
  4. APAC $812.7 Mn
  5. Europe $540.0 Mn
  6. China $293.9 Mn
  7. Canada $285.2 Mn
  8. Japan $218.6 Mn
  9. Germany $133.7 Mn
  10. Latin America $133.6 Mn
  11. Middle East $116.0 Mn
  12. UK $86.2 Mn
  13. Italy $82.5 Mn
  14. Brazil $81.7 Mn
  15. France $76.7 Mn
  16. Ecuador $71.5 Mn
  17. India $67.7 Mn
  18. Africa $58.5 Mn
  19. Saudi Arabia $58.2 Mn
  20. Spain $55.6 Mn
  21. Mexico $55.5 Mn
  22. Australia $45.3 Mn
  23. Russia $31.5 Mn
  24. New Zealand $30.4 Mn
  25. South Africa $20.2 Mn
  26. UAE $18.3 Mn
  27. Egypt $8.5 Mn
  28. Philippines $8.4 Mn
  29. Malaysia $5.5 Mn
  30. Hong Kong $5.3 Mn
  31. Singapore $4.5 Mn
  32. Thailand $4.3 Mn
  33. Kenya (this report) $2.4 Mn

Report snapshot

Kenya Insomnia Treatment Market Analysis at a glance
Market size, 2025$2.4 Mn placeholder estimate
Forecast, 2034$3.9 Mn placeholder estimate
Growth (CAGR), 2025–20345.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledInsomnia Therapeutics
SegmentsTreatment, type and end user (see all)
Key playersIdorsia, Merck & Co., Inc., Eisai Co., Sanofi, Big Health (see all)
Regulator in KenyaPPBSource: Pharmacy and Poisons Board. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Kenya Insomnia Treatment Market Analysis Executive Summary

Insomnia treatment helps people fall and stay asleep with newer medicines, digital CBT for insomnia and sleep aids.

Key segments of the insomnia Treatment market include treatment (Orexin Receptor Antagonists, Z-Drugs and Melatonin Agonists) and type (Short-Term Insomnia and Chronic Insomnia).

Bar chart: Kenya Insomnia Treatment market size, 2024–2034, placeholder estimates. $2.2 Mn in 2024, $2.4 Mn in 2025 and $3.9 Mn in 2034, 5.8% CAGR.
Kenya Insomnia Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Kenya Insomnia Treatment Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the insomnia Treatment market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the insomnia Treatment market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the insomnia Treatment market.

Competitive Landscape for Insomnia Treatment Market in Kenya

The insomnia Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insomnia Treatment Market in Kenya

Insomnia Treatment in Kenya: rules, payment and health figures

The Pharmacy and Poisons Board (PPB) registers medicines before sale.⁠[1] The Social Health Authority (SHA) replaced the National Health Insurance Fund (NHIF) in October 2024.⁠[2] Suicide rate: 7.9 per 100,000 people in 2023, the latest WHO figure for Kenya.⁠[3]

[1] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[2] Social Health Authority. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for insomnia Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Kenya.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insomnia Treatment right now, from free public sources.

Latest research 369 papers since 2021 (worldwide)

  1. Commentary: The "efficacy window" phenomenon of daridorexant in insomnia treatment: a dose-dependent time-course meta-analysis. Frontiers in pharmacology, 2026
  2. Global research landscape and emerging frontiers in primary insomnia treatment (2005-2025): A bibliometric analysis. Medicine, 2026
  3. Student-supervisor relationship and suicidal behavior among Chinese medical postgraduates: The mediating effect of insomnia and depression. Journal of education and health promotion, 2026
  4. An innovative hybrid cognitive behavioral therapy for insomnia approach to insomnia treatment: a retrospective chart review study. Family practice, 2026
  5. Migration Characteristics and Mechanism of Active Components From Jieyu Anshen Granule in Different Insomnia Mouse Models. Rapid communications in mass spectrometry : RCM, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insomnia Treatment in context

Kenya compared

  • Suicide rate: 7.9 per 100,000 people (2023). World: 9.2 per 100,000 people (2023). 4th highest of the 17 countries we cover in Africa.[1]
  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 17 countries we cover in Africa.[2]
  • Doctors: 0.29 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 6th highest of the 17 countries we cover in Africa.[3]

[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insomnia Treatment market in Kenya?
Placeholder estimate: about $2.4 Mn in 2025, rising to about $3.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insomnia Treatment market in Kenya growing?
Placeholder estimate: about 5.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insomnia Treatment market report cover?
The report splits the market by treatment (Orexin Receptor Antagonists, Z-Drugs, Melatonin Agonists, Digital CBT-I), type (Short-Term Insomnia, Chronic Insomnia) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Insomnia Treatment market?
Key players include Idorsia, Merck & Co., Inc., Eisai Co., Sanofi and Big Health.
What is driving the Insomnia Treatment market?
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the insomnia Treatment market. Governments and employers are investing more in mental health care.
Who regulates Insomnia Treatment in Kenya?
The Pharmacy and Poisons Board (PPB) registers medicines before sale. Source: Pharmacy and Poisons Board. Checked 14 Nov 2026.
How is healthcare paid for in Kenya?
The Social Health Authority (SHA) replaced the National Health Insurance Fund (NHIF) in October 2024. Source: Social Health Authority. Checked 14 Nov 2026.
What does WHO report for Kenya?
Suicide rate: 7.9 per 100,000 people in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
How many people in Kenya are 65 or older?
3.0% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Insomnia Treatment?
PubMed lists 369 papers on Insomnia Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Insomnia Treatment in Kenya? Our analysts can size it for your plan. Talk to us See the public data Suicide rate for every country, free. Open the Public Health Dashboard

From our blog

Adaptogens: Ancient Herbs, Modern Market170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and… Stress and Mood Supplements: Ashwagandha and BeyondDepression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress… Sleep Aids: Why So Many People Can't SleepAbout 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Kenya

See all
Same topic, other categories

Related on sleep and mental health

See the topic